Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16018-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#16018-1-AP, RRID:AB_2150711
- Product name
- NAP1L4 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated NAP1L4 antibody (Cat. #16018-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Phase separation and toxicity of C9orf72 poly(PR) depends on alternate distribution of arginine.
NAP1L1 and NAP1L4 Binding to Hypervariable Domain of Chikungunya Virus nsP3 Protein Is Bivalent and Requires Phosphorylation.
Nucleosome assembly protein 1-like 4, a new therapeutic target for proliferation and invasion of melanoma cells.
A novel immuno-competitive capture mass spectrometry strategy for protein-protein interaction profiling reveals that LATS kinases regulate HCV replication through NS5A phosphorylation.
Chen C, Yamanaka Y, Ueda K, Li P, Miyagi T, Harada Y, Tezuka S, Narumi S, Sugimoto M, Kuroda M, Hayamizu Y, Kanekura K
The Journal of cell biology 2021 Nov 1;220(11)
The Journal of cell biology 2021 Nov 1;220(11)
NAP1L1 and NAP1L4 Binding to Hypervariable Domain of Chikungunya Virus nsP3 Protein Is Bivalent and Requires Phosphorylation.
Dominguez F, Shiliaev N, Lukash T, Agback P, Palchevska O, Gould JR, Meshram CD, Prevelige PE, Green TJ, Agback T, Frolova EI, Frolov I
Journal of virology 2021 Jul 26;95(16):e0083621
Journal of virology 2021 Jul 26;95(16):e0083621
Nucleosome assembly protein 1-like 4, a new therapeutic target for proliferation and invasion of melanoma cells.
Mizuhashi S, Fukushima S, Ishibashi T, Kuriyama H, Kimura T, Kanemaru H, Kajihara I, Makino K, Miyashita A, Aoi J, Kita K, Ihn H
Journal of dermatological science 2021 Apr;102(1):16-24
Journal of dermatological science 2021 Apr;102(1):16-24
A novel immuno-competitive capture mass spectrometry strategy for protein-protein interaction profiling reveals that LATS kinases regulate HCV replication through NS5A phosphorylation.
Meistermann H, Gao J, Golling S, Lamerz J, Le Pogam S, Tzouros M, Sankabathula S, Gruenbaum L, Nájera I, Langen H, Klumpp K, Augustin A
Molecular & cellular proteomics : MCP 2014 Nov;13(11):3040-8
Molecular & cellular proteomics : MCP 2014 Nov;13(11):3040-8
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HeLa cells were subjected to SDS PAGE followed by western blot with 16018-1-AP(NAP1L4 antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human liver using 16018-1-AP(NAP1L4 antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The NAP1L4 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human NAP1L4. This antibody recognizes human, mouse, rat antigen. The NAP1L4 antibody has been validated for the following applications: ELISA, WB, IHC analysis.